New York GU Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies | Conference

Peter Humphrey, MD, PhD, Discusses Current Role of Pathology in RCC
May 09, 2022

At the 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies, Peter Humphrey, MD, PhD, spoke about the role of pathology in renal cell carcinoma.

Gennady Bratslavsky, MD, Reviews Emerging Research in RCC
May 04, 2022

Gennady Bratslavsky, MD, at the 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies, spoke about which research in renal cell carcinoma has the greatest potential for clinical impact.

Daniel P. Petrylak, MD, Talks About Importance of Mentorships in Genitourinary Oncology
May 02, 2022

At the 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies, Daniel P. Petrylak, MD, reflects upon mentorship during his training to become an oncologist.

Peter Humphrey, MD, PhD, Discusses Histology and Clinical Trial Enrollment in RCC
April 25, 2022

At the 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies, Peter Humphrey, MD, PhD, spoke about how enrollment for specific trials in renal cell carcinoma may incorporate a patient’s tumor histology.

Daniel P. Petrylak, MD, Reviews Ongoing Clinical Trials in Bladder Cancer
April 22, 2022

At the 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies, Daniel P. Petrylak, MD, spoke about ongoing trials may hold promise for the treatment of patients with bladder cancer.

Susan F. Slovin, MD, PhD, Reviews Future Landscape of Systemic Therapies for Prostate Cancer
April 21, 2022

Susan F. Slovin, MD, PhD, spoke about how new approaches can support clinical practice guidelines and physician intuition in treating patients with prostate cancer.

Scott T. Tagawa, MD, Talks Current Initiatives in Prostate Cancer
April 20, 2022

Scott T. Tagawa, MD, spoke about potential approvals in the coming year for prostate cancer.

Gennady Bratslavsky, MD, on Adjuvant Therapy in RCC
April 15, 2022

Gennady Bratslavsky, MD, spoke about the role of adjuvant therapy in renal cell carcinoma at the 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies.

Peter Humphrey, MD, PhD, Talks Multidisciplinary Aspects of Oncology Research
April 07, 2022

At the 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies, Peter Humphrey, MD, PhD, spoke about how the conference catered to the multidisciplinary audience, and what he learned from that.

Gennady Bratslavsky, MD, Discusses Future of Surgery in RCC
March 24, 2022

Gennady Bratslavsky, MD, spoke about the evolving field of surgery for renal cell carcinoma at the 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies.